Controversies in RBC transfusion in the critically ill.
Transfusion practice has been under great scrutiny over the last 2 decades. The examination of transfusion risks and benefits have been particularly important in the critically ill patient population. This review will examine some of the important controversies still surrounding the use of RBC transfusion in the critically ill patient.
Hébert
Paul C
PC
Centre for Transfusion Research, University of Ottawa, and Clinical Epidemiology Program of the Ottawa Health Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada. phebert@ohri.ca
Tinmouth
Alan
A
Corwin
Howard L
HL
D002318:Cardiovascular Diseases / Q000628:therapy; D016638:Critical Illness / Q000628:therapy*; D017707:Erythrocyte Transfusion / Q000009:adverse effects; D006801:Humans; D018570:Risk Assessment; D018805:Sepsis / Q000628:therapy; D012772:Shock, Septic / Q000628:therapy